Measurement of anti-acetylcholine receptor auto-antibodies in myasthenia gravis. 1995

K J Steenkamp, and W Duim, and M S Myer, and S C Malfeld, and R Anderson
Department of Immunology, University of Pretoria.

Two different acetylcholine receptor (AChR) preparations derived from amputated human muscle (AChRAMP) and from the human rhabdomyosarcoma cell line TE671 (AChRTE671) were compared in radio-immunoprecipitation assays for the detection of AChR auto-antibodies in serum specimens from 20 patients with proven myasthenia gravis. Tests performed with the AChRTE671 and AChRAMP antigen preparations were positive in all the patients and in 19/20 respectively. A high degree of correlation (r = 0.94) was evident between the two auto-antigen preparations. Assays based on the use of TE671-derived antigen represent a useful alternative to the conventional assay using AChRAMP for the detection of AChR auto-antibodies.

UI MeSH Term Description Entries
D009157 Myasthenia Gravis A disorder of neuromuscular transmission characterized by fatigable weakness of cranial and skeletal muscles with elevated titers of ACETYLCHOLINE RECEPTORS or muscle-specific receptor tyrosine kinase (MuSK) autoantibodies. Clinical manifestations may include ocular muscle weakness (fluctuating, asymmetric, external ophthalmoplegia; diplopia; ptosis; and weakness of eye closure) and extraocular fatigable weakness of facial, bulbar, respiratory, and proximal limb muscles. The disease may remain limited to the ocular muscles (ocular myasthenia). THYMOMA is commonly associated with this condition. Anti-MuSK Myasthenia Gravis,MuSK MG,MuSK Myasthenia Gravis,Muscle-Specific Receptor Tyrosine Kinase Myasthenia Gravis,Muscle-Specific Tyrosine Kinase Antibody Positive Myasthenia Gravis,Myasthenia Gravis, Generalized,Myasthenia Gravis, Ocular,Anti MuSK Myasthenia Gravis,Generalized Myasthenia Gravis,Muscle Specific Receptor Tyrosine Kinase Myasthenia Gravis,Muscle Specific Tyrosine Kinase Antibody Positive Myasthenia Gravis,Myasthenia Gravis, Anti-MuSK,Myasthenia Gravis, MuSK,Ocular Myasthenia Gravis
D011950 Receptors, Cholinergic Cell surface proteins that bind acetylcholine with high affinity and trigger intracellular changes influencing the behavior of cells. Cholinergic receptors are divided into two major classes, muscarinic and nicotinic, based originally on their affinity for nicotine and muscarine. Each group is further subdivided based on pharmacology, location, mode of action, and/or molecular biology. ACh Receptor,Acetylcholine Receptor,Acetylcholine Receptors,Cholinergic Receptor,Cholinergic Receptors,Cholinoceptive Sites,Cholinoceptor,Cholinoceptors,Receptors, Acetylcholine,ACh Receptors,Receptors, ACh,Receptor, ACh,Receptor, Acetylcholine,Receptor, Cholinergic,Sites, Cholinoceptive
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D001323 Autoantibodies Antibodies that react with self-antigens (AUTOANTIGENS) of the organism that produced them. Autoantibody
D012208 Rhabdomyosarcoma A malignant solid tumor arising from mesenchymal tissues which normally differentiate to form striated muscle. It can occur in a wide variety of sites. It is divided into four distinct types: pleomorphic, predominantly in male adults; alveolar (RHABDOMYOSARCOMA, ALVEOLAR), mainly in adolescents and young adults; embryonal (RHABDOMYOSARCOMA, EMBRYONAL), predominantly in infants and children; and botryoidal, also in young children. It is one of the most frequently occurring soft tissue sarcomas and the most common in children under 15. (From Dorland, 27th ed; Holland et al., Cancer Medicine, 3d ed, p2186; DeVita Jr et al., Cancer: Principles & Practice of Oncology, 3d ed, pp1647-9) Rhabdomyosarcomas
D014407 Tumor Cells, Cultured Cells grown in vitro from neoplastic tissue. If they can be established as a TUMOR CELL LINE, they can be propagated in cell culture indefinitely. Cultured Tumor Cells,Neoplastic Cells, Cultured,Cultured Neoplastic Cells,Cell, Cultured Neoplastic,Cell, Cultured Tumor,Cells, Cultured Neoplastic,Cells, Cultured Tumor,Cultured Neoplastic Cell,Cultured Tumor Cell,Neoplastic Cell, Cultured,Tumor Cell, Cultured
D015531 Radioimmunoprecipitation Assay Sensitive assay using radiolabeled ANTIGENS to detect specific ANTIBODIES in SERUM. The antigens are allowed to react with the serum and then precipitated using a special reagent such as PROTEIN A sepharose beads. The bound radiolabeled immunoprecipitate is then commonly analyzed by gel electrophoresis. Farr Assay,Radioimmunoprecipitation Analysis,Analyses, Radioimmunoprecipitation,Analysis, Radioimmunoprecipitation,Assay, Farr,Assay, Radioimmunoprecipitation,Assays, Radioimmunoprecipitation,Radioimmunoprecipitation Analyses,Radioimmunoprecipitation Assays

Related Publications

K J Steenkamp, and W Duim, and M S Myer, and S C Malfeld, and R Anderson
May 1981, Italian journal of neurological sciences,
K J Steenkamp, and W Duim, and M S Myer, and S C Malfeld, and R Anderson
January 2009, Frontiers of neurology and neuroscience,
K J Steenkamp, and W Duim, and M S Myer, and S C Malfeld, and R Anderson
January 1993, Journal of neurology, neurosurgery, and psychiatry,
K J Steenkamp, and W Duim, and M S Myer, and S C Malfeld, and R Anderson
October 2001, Presse medicale (Paris, France : 1983),
K J Steenkamp, and W Duim, and M S Myer, and S C Malfeld, and R Anderson
December 1980, Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine,
K J Steenkamp, and W Duim, and M S Myer, and S C Malfeld, and R Anderson
October 1975, The New England journal of medicine,
K J Steenkamp, and W Duim, and M S Myer, and S C Malfeld, and R Anderson
April 1983, Harefuah,
K J Steenkamp, and W Duim, and M S Myer, and S C Malfeld, and R Anderson
January 1981, Muscle & nerve,
K J Steenkamp, and W Duim, and M S Myer, and S C Malfeld, and R Anderson
February 1979, Lancet (London, England),
K J Steenkamp, and W Duim, and M S Myer, and S C Malfeld, and R Anderson
January 1981, Journal of neurology,
Copied contents to your clipboard!